167 related articles for article (PubMed ID: 12066205)
1. Expression of cyclooxygenase-2 and vascular endothelial growth factor in pancreatic tumors.
Aoki T; Nagakawa Y; Tsuchida A; Kasuya K; Kitamura K; Inoue K; Ozawa T; Koyanagi Y; Itoi T
Oncol Rep; 2002; 9(4):761-5. PubMed ID: 12066205
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of cyclooxygenase-2 and vascular endothelial growth factor in pancreaticobiliary maljunction.
Tsuchida A; Nagakawa Y; Kasuya K; Itoi T; Endo M; Ozawa T; Aoki T; Koyanagi Y
Oncol Rep; 2003; 10(2):339-43. PubMed ID: 12579269
[TBL] [Abstract][Full Text] [Related]
3. Mucinous colon carcinomas with microsatellite instability have a lower microvessel density and lower vascular endothelial growth factor expression.
Wendum D; Boëlle PY; Rigau V; Sebbagh N; Olschwang S; Mourra N; Parc R; Trugnan G; Masliah J; Fléjou JF
Virchows Arch; 2003 Feb; 442(2):111-7. PubMed ID: 12596060
[TBL] [Abstract][Full Text] [Related]
4. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
5. Role of COX-2, VEGF and cyclin D1 in mammary infiltrating duct carcinoma.
Lim SC
Oncol Rep; 2003; 10(5):1241-9. PubMed ID: 12883688
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical analysis and in situ hybridization of cyclooxygenase-2 expression in intraductal papillary-mucinous tumors of the pancreas.
Niijima M; Yamaguchi T; Ishihara T; Hara T; Kato K; Kondo F; Saisho H
Cancer; 2002 Mar; 94(5):1565-73. PubMed ID: 11920515
[TBL] [Abstract][Full Text] [Related]
7. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of vascular endothelial growth factor expression in gastric cancer.
Kakeji Y; Koga T; Sumiyoshi Y; Shibahara K; Oda S; Maehara Y; Sugimachi K
J Exp Clin Cancer Res; 2002 Mar; 21(1):125-9. PubMed ID: 12071518
[TBL] [Abstract][Full Text] [Related]
9. Angiostatin expression in endometrial cancer.
Yabushita H; Noguchi M; Kinoshita S; Kishida T; Sawaguchi K; Noguchi M
Oncol Rep; 2002; 9(6):1193-6. PubMed ID: 12375018
[TBL] [Abstract][Full Text] [Related]
10. Correlation of cyclooxygenase-2 pathway and VEGF expression in head and neck squamous cell carcinoma.
Lim SC; Park SY; Do NY
Oncol Rep; 2003; 10(5):1073-9. PubMed ID: 12883661
[TBL] [Abstract][Full Text] [Related]
11. Expression of cyclo-oxygenase 1 and 2, prostaglandin E synthase and transforming growth factor beta1, and their relationship with vascular endothelial growth factors A and C, in primary adenocarcinoma of the small intestine.
von Rahden BH; Brücher BL; Langner C; Siewert JR; Stein HJ; Sarbia M
Br J Surg; 2006 Nov; 93(11):1424-32. PubMed ID: 17022010
[TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2 promotes prostate cancer progression.
Fujita H; Koshida K; Keller ET; Takahashi Y; Yoshimito T; Namiki M; Mizokami A
Prostate; 2002 Nov; 53(3):232-40. PubMed ID: 12386924
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis.
Nakashima T; Kondoh S; Kitoh H; Ozawa H; Okita S; Harada T; Shiraishi K; Ryozawa S; Okita K
Int J Mol Med; 2003 Jan; 11(1):33-9. PubMed ID: 12469214
[TBL] [Abstract][Full Text] [Related]
14. Expression of cyclooxygenase-2 in primary and remnant gastric carcinoma: comparing it with p53 accumulation, Helicobacter pylori infection, and vascular endothelial growth factor expression.
Kawabe A; Shimada Y; Uchida S; Maeda M; Yamasaki S; Kato M; Hashimoto Y; Ohshio G; Matsumoto M; Imamura M
J Surg Oncol; 2002 Jun; 80(2):79-88. PubMed ID: 12173384
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M
Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of cyclooxygenase-2 and tumor angiogenesis in human gastric cancer.
Koga T; Shibahara K; Kabashima A; Sumiyoshi Y; Kimura Y; Takahashi I; Kakeji Y; Maehara Y
Hepatogastroenterology; 2004; 51(60):1626-30. PubMed ID: 15532792
[TBL] [Abstract][Full Text] [Related]
17. COX-2 status in relation to tumor microvessel density and VEGF expression: analysis in ovarian carcinoma patients with low versus high survival rates.
Raspollini MR; Amunni G; Villanucci A; Boddi V; Baroni G; Taddei A; Taddei GL
Oncol Rep; 2004 Feb; 11(2):309-13. PubMed ID: 14719060
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological significance of vascular endothelial growth factor-C and cyclooxygenase-2 in esophageal squamous cell carcinoma.
Byeon JS; Jung HY; Lee YJ; Lee D; Lee GH; Myung SJ; Yang SK; Hong WS; Kim JH; Min YI; Kim JS
J Gastroenterol Hepatol; 2004 Jun; 19(6):648-54. PubMed ID: 15151619
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis.
Soumaoro LT; Uetake H; Takagi Y; Iida S; Higuchi T; Yasuno M; Enomoto M; Sugihara K
Dis Colon Rectum; 2006 Mar; 49(3):392-8. PubMed ID: 16474989
[TBL] [Abstract][Full Text] [Related]
20. Localization of vascular endothelial growth factor and its receptors in digestive endocrine tumors: correlation with microvessel density and clinicopathologic features.
La Rosa S; Uccella S; Finzi G; Albarello L; Sessa F; Capella C
Hum Pathol; 2003 Jan; 34(1):18-27. PubMed ID: 12605362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
